Trial Details
Not recruitingBasic Information
| Clinical ID | c3325 |
|---|---|
| Identifier | NCT00724529 |
| Trial Title | Post Marketing Surveillance of Remicade in Inflammatory Bowel Disease (IBD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Crohn's Disease;Ankylosing Spondylitis |
| Interventions | Biological: Infliximab |
Participant Information
| Sponsor | Janssen Korea, Ltd., Korea |
|---|---|
| City | - |
| Country/Region | South Korea |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Observational |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |